EP Patent

EP4114393A4 — METHOD FOR TREATING AND PREVENTING LUNG INFECTIONS BY ADMINISTRATING TAFENOCHIN

Assigned to 60 Degrees Pharmaceuticals Inc · Expires 2024-04-10 · 2y expired

What this patent protects

Patent listed against tafenoquine-succinate.

Drugs covered by this patent

tafenoquine-succinate (TAFENOQUINE SUCCINATE)

Patent Metadata

Patent number: EP4114393A4
Jurisdiction: EP
Classification: —
Expires: 2024-04-10
Drug substance claim: No
Drug product claim: No
Assignee: 60 Degrees Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.